↓ Skip to main content

Crizotinib and Doxorubicin Cooperatively Reduces Drug Resistance by Mitigating MDR1 to Increase Hepatocellular Carcinoma Cells Death

Overview of attention for article published in Frontiers in oncology, May 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
9 Mendeley